Compounds and their uses

Details Compounds and their uses Compounds and their uses

2007-06-26

2007-06-26

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S004100, C536S017200, C536S018400, C536S018700

Reexamination Certificate

active

11133018

ABSTRACT:
Compounds having a mimetic or antagonistic property of an inositol phosphoglycan, and the uses of these compounds are disclosed, together with the use, e.g. to treat a condition ameliorated by administration of an IPG second messenger or an IPG antagonist thereof. In particular, the compounds are based on the 1,6 linkage of a sugar residue and a cyclitol.

REFERENCES:
patent: 5268272 (1993-12-01), Mullner et al.
patent: 5395828 (1995-03-01), Schiebler et al.
patent: 5550166 (1996-08-01), Ostlund et al.
patent: 5652221 (1997-07-01), Larner et al.
patent: 6004938 (1999-12-01), Frick et al.
patent: 6271204 (2001-08-01), Rademacher et al.
patent: 6303580 (2001-10-01), Rademacher et al.
patent: 6716826 (2004-04-01), Martin-Lomas et al.
patent: 6759390 (2004-07-01), Martin-Lomas et al.
patent: 6900182 (2005-05-01), Rademacher et al.
patent: 0 520 372 (1992-12-01), None
patent: 0 559 064 (1993-09-01), None
patent: 0 845 475 (1998-06-01), None
patent: 63196596 (1988-08-01), None
patent: 03237101 (1991-10-01), None
patent: 04120089 (1992-04-01), None
patent: 06293790 (1994-10-01), None
patent: WO 96/14075 (1996-05-01), None
patent: WO 98/10791 (1998-03-01), None
patent: WO 98/11116 (1998-03-01), None
patent: WO 98/11117 (1998-03-01), None
patent: WO 98/11435 (1998-03-01), None
patent: WO 98/50049 (1998-11-01), None
patent: WO 99/06421 (1999-02-01), None
patent: WO 99/38516 (1999-08-01), None
patent: WO 00/15254 (2000-03-01), None
patent: WO 00/39141 (2000-07-01), None
Crossman, A. et al, Carbohydrate Research, 1999, 321(1-2), 42-51.
Schweizer, T.F. et al, J. Sci. Fd. Agric. 1978, 29, 148-154.
Schweizer, T.F., et al., J. Sci. Fd. Agric., 29:148-154, (1978).
Fernandez De La Pradilla, R. et al., “Improved preparation of acetals ofmyo-inositol and its (±)-1-benzyl ether: conformational analysis of di-O-isopropylidene-myo-inositol derivatives”; Carbohydrate Research, 207: 249-257 (1990).
Bernabé, M. et al., “Chiral recognition of 1-O-allyl and 1-O-benzyl-D—and -L-myo-inositol by cyclomalto-hexaose and -heptaose (α-and β-cyclodextrin)”; Carbohydrate Research, 208: 255-259 (1990).
Zapata, A. et al., “Novel Highly Regioselective O-Alkylation and O-Acylation ofmyo-Inositol”; J. Org. Chem., 56: 444-447 (1991).
Jaramillo, C. et al., “Synthesis of 1D-1,2-anhydro-myoinositol”; Carbohydrate Research, 209: 296-298 (1991).
Jaramillo, C. et al., “Approaches to the Synthesis of Glycosyl Phosphatidyl Inositols. Enantioselective Synthesis of Optically Activechiro- andmyo-Inositols.”; Tetrahedron Letters, 32(22): 2501-2504 (1991).
Vasella, A. et al., “194. Convenient Synthesis of 2-Azido-2-deoxy-aldoses by Diazo Transfer”; Helvetica Chimica Acta, 74: 2073-2077 (1991).
Aguiló, A. et al., “The Regioselective Synthesis of Enantiomerically Puremyo-Inositol Derivatives. Efficient Synthesis ofmyo-Inositol 1,4,5-trisphosphate.”; Tetrahedron Letters, 33(3): 401-404 (1992).
Zapata, A. et al., “Building blocks for the synthesis of glycosyl-myo-inositols involved in the insulin intracellular signalling process”; Carbohydrate Research, 234: 93-106 (1992).
Caro, H. et al., “Syntheses and insulin-like activity of phosphorylated galactose derivatives”; Carbohydrate Research, 240: 119-131 (1993).
Singh, K. et al., “Synthesis of Oligosaccarides Structurally Related to E-Selectin Ligands”; J. Chem. Soc., Chem. Commun., 775-776 (1994).
Chiara, J.L. et al., “A Stereoselective Route to Enantiomerically Puremyo-Inositol Derivatives Starting from D-Mannitol”; Tetrahedron Letters, 35(18): 2969-2972 (1994).
Zapata, A. et al., “Synthesis and investigation of the possible insulin-like activity of 1D-4-O-and 1D-6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-myo-inositol 1-phosphate and 1D-6-O-(2-amino-2-deoxy-α-D- glucopyranosyl)-myo-inositol 1,2-(cyclic phosphate)”; Carbohydrate Research, 264: 21-32 (1994).
Jaramillo, C. et al., “An Effective Strategy for the Synthesis of 6-O-(2-Amino-2-deoxy-α-D-glucopyranosyl)-D-chiro- and -D-myo-inositol 1-Phosphate Related to Putative Insulin Mimetics”; J. Org. Chem., 59: 3135-3141 (1994).
Varela-Nieto, I. et al., “Cell Signalling by Inositol Phosphoglycans from Different Species”; Comp. Biochem. Physiol., 115B(2): 223-241 (1996).
Martin-Lomas, M. et al., “The solution conformation of glycosyl Inositols related to inositolphosphoglycan (IPG) mediators”; Tetrahedron: Asymmetry, 11: 37-51 (2000).
Baeschlin, D.K. et al., “1,2-Diacetals in Synthesis: Total Synthesis of a Glycosylphosphatidylinositol Anchor ofTrypanosoma brucei”; Chem. Eur. J., 6(1): 172-186 (2000).
Frick, W. et al., “Structure-Activity Relationship of Synthetic Phosphoinositolglycans Mimicking Metabolic Insulin Action”; Biochemistry, 37(38): 13421-13436 (1998).
Jaworek, C.H. et al., “Synthesis of an Inositol-Containing Trisaccharide Related to Insulin Signal Transduction”; Tetrahedron Letters, 40: 667-670 (1999).
Deeg, M.A. et al., “Inositol Glycan Phosphate derived from Human Erythrocyte Acetylcholinesterase Glycolipid Anchor and Inositol Cyclic 1,2-Phosphate Antagonize Glucagon Activation of Glycogen Phosphorylase”; Diabetes, 42(9): 1318-1323 (1993).
Güther, M.L.S. et al., “Molecular species analysis and quantification of the glycosylphosphatidylinositol intermediate glycolipid C fromTrypanosoma brucei”, Mol. Biochem. Parasitol., 77(2): 137-145 (1996).
Mayer, T.G. et al., “Glycosyl Phosphatidylinositol (GPI) Anchor Synthesis Based on Versatile Building Blocks—Total Synthesis of a GPI Anchor of Yeast”; Eur. J. Org. Chem. 1153-1165 (1999).
Müller, G. et al., “Phosphoinositolglycan-Peptides from Yeast Potently Induce Metabolic Insulin Actions in Isolated Rat Adipocytes, Cardiomyocytes, and Diaphragms”; Endocrinology, 138: 3459-3475 (1997).
Baeschlin, D.K. et al., “Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor ofTrypanosoma brucei”; Angew Chem. Int. Ed., 37(24): 3423-3427 (1998).
Derappe, C. et al., “Characterization of a New Oligosaccharide Containingmyo-Inositol Found in Pregnancy Urine”; Carbohydrate Research, 115: 221-229 (1983).
Angyal, S.J. et al., “Cyclitols. Part XXII. Synthesis of Some Mannosyl- and Mannosyl- mannosyl-myoinositols, and of Galactinol”; J. Chem. Soc. (C), 433-438 (1966).
Reddy, K.K. et al., “Insulin Second Messengers: Synthesis of 6-O-(2-Amino-2-deoxy-α-D-glucopyranosyl)-D-chiro-inositol-1-phosphate”, Tetrahedron Lets., 34(49: 7869-7872 (1993).
Plourde, R. et al., “Synthesis of a Potentially Insulin-Mimetic Phosphodisaccharide”, Tetrahedron Lets., 31(19): 2693-2696 (1990).
Stralfors, P., “Insulin second messengers”; Bioessays, 19: 327-335 (1997).
Field, M.C., “Is there evidence for phospho-oligosaccharides as insulin mediators?”; Glycobiology, 7: 161-168 (1997).
Jones, D.R. et al., “The role of glycosyl-phosphatidylinositol in signal transduction”; Int. J. Biochem. Cell Biol., 30: 313-326 (1998).
Mato, J.M. et al., “Partial Structure of an Insulin-Sensitive Glycophospholipid”; Biochem. Biophys. Res. Commun., 146: 764-770 (1987).
Larner, J., “Rat Liver Insulin Mediator Which Stimulates Pyruvate Dehydrogenase Phosphatase Contains Galactosamine and D-Chiroinositol”; Biochem. Biophys. Res. Commun., 151: 1416-1426 (1988).
Caro, H.N. et al., “Isolation and Partial Characterisation of Insulin-Mimetic Inositol Phosphoglycans from Human Liver”; Biochem. Mol. Med., 61: 214-228 (1997).
Gigg, R. et al., “Synthesis of Glycosylphosphatidylinositol Anchors”; in “Glycopeptides and Related Compounds”; Large & Warren, Eds., Marcel Dekker, New York, 327-392 (1997).
Corey, E.J. et al., “Protection of Hydroxyl Groups astert-B

Affiliated with

Also associated with

Rating

Compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and their uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3880008